# Thomas C. Smyrk

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thomas-c-smyrk/

## Facts

| Field | Value |
| --- | --- |
| Citations | 77,455 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 124 |
| i10-index | 403 |
| Last Known Institution | Mayo Clinic in Arizona |
| OpenAlex ID | https://openalex.org/A5049580044 |
| ORCID iD | https://orcid.org/0000-0001-6194-7853 |
| Works | 914 |

## Researcher papers

Showing 12 of 14.

- [Consensus statement on the pathology of IgG4-related disease](https://scholariq.org/papers/consensus-statement-on-the-pathology-of-igg4-related-disease/)
- [Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma](https://scholariq.org/papers/integrated-genomic-characterization-of-pancreatic-ductal-adenocarcinoma/)
- [Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience](https://scholariq.org/papers/diagnosis-of-autoimmune-pancreatitis-the-mayo-clinic-experience/)
- [Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy](https://scholariq.org/papers/immunoglobulin-g4-associated-cholangitis-clinical-profile-and-response-to/)
- [Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations](https://scholariq.org/papers/recommendations-for-the-nomenclature-of-igg4-related-disease-and-its-individual/)
- [Rituximab for IgG4-related disease: a prospective, open-label trial](https://scholariq.org/papers/rituximab-for-igg4-related-disease-a-prospective-open-label-trial/)
- [Value of Serum IgG4 in the Diagnosis of Autoimmune Pancreatitis and in Distinguishing It From Pancreatic Cancer](https://scholariq.org/papers/value-of-serum-igg4-in-the-diagnosis-of-autoimmune-pancreatitis-and-in/)
- [Differences in Clinical Profile and Relapse Rate of Type 1 Versus Type 2 Autoimmune Pancreatitis](https://scholariq.org/papers/differences-in-clinical-profile-and-relapse-rate-of-type-1-versus-type-2/)
- [Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience](https://scholariq.org/papers/treatment-of-relapsing-autoimmune-pancreatitis-with-immunomodulators-and/)
- [Diagnosis of IgG4-Related Tubulointerstitial Nephritis](https://scholariq.org/papers/diagnosis-of-igg4-related-tubulointerstitial-nephritis/)
- [Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis](https://scholariq.org/papers/symptoms-have-modest-accuracy-in-detecting-endoscopic-and-histologic-remission/)
- [Controversies in Clinical Pancreatology](https://scholariq.org/papers/controversies-in-clinical-pancreatology/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Colorectal Cancer Screening and Detection](https://scholariq.org/topics/colorectal-cancer-screening-and-detection/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Mayo Clinic in Arizona](https://scholariq.org/institutions/mayo-clinic-in-arizona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.